This trial is testing whether light therapy can help improve symptoms for people who have post-concussion syndrome after a mild to moderate brain injury.
- Post-Concussion Syndrome
- Post Concussive Syndrome, Chronic
2 Primary · 4 Secondary · Reporting Duration: Visit 1/Baseline to Visit 3/End of Treatment (8 weeks)
2 Treatment Groups
1 of 2
1 of 2
20 Total Participants · 2 Treatment Groups
Primary Treatment: BioFlex Dualport System · Has Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What is the current roster for participants in this medical trial?
"Affirmative, the clinical trial is indeed recruiting. According to records hosted on clinicaltrials.gov, it was posted on January 27th 2022 and most recently edited on August 8th 2022 with a recruitment goal of 20 people at 2 different sites." - Anonymous Online Contributor
Is recruitment for this project ongoing?
"Absolutely. The clinical trial website indicates that this research initiative, which was published on January 27th 2022, is actively recruiting participants. At the moment, there are 20 openings across two different sites." - Anonymous Online Contributor
What are the chief aims of this experiment?
"This medical trial has two primary goals. Firstly, to assess the response timing of ERPs (N100, P300 and N400) gathered from NeuroCatch Platform 2 over an 8-week period. Secondly, researchers are looking at Rivermead Post Concussion Symptoms Questionnaire Score (ranging 0-64), Pain Catastrophizing Scale Score (0-52) and Number of Adverse Device Effects for secondary outcomes." - Anonymous Online Contributor